Form 4: Amedisys CEO Richard Ashworth Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Amedisys CEO Richard Ashworth disposed of 11,079 shares of common stock to cover tax obligations related to the accelerated vesting of restricted stock units.
Summary
- Richard Ashworth, the President and CEO of Amedisys Inc., disposed of 11,079 shares of common stock on December 27, 2024.
- The shares were sold at a price of $89.96 per share.
- This transaction was to cover tax obligations arising from the accelerated vesting of restricted stock units (RSUs).
- The accelerated vesting was implemented to mitigate potential tax implications under Sections 280G and 4999 of the Internal Revenue Code.
- Following the transaction, Ashworth directly owns 101,609 shares of Amedisys common stock.
- The accelerated RSUs are subject to certain forfeiture conditions as per a letter agreement signed by Ashworth.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is not indicative of any positive or negative sentiment towards the company's performance or future prospects.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when stock options or restricted stock units vest.
Comparison to Industry Standards
- Executive stock transactions are common across publicly traded companies, particularly when dealing with stock-based compensation.
- The sale of shares to cover tax obligations is a standard practice and does not indicate any unusual activity compared to other companies in the healthcare sector or other industries.
- Similar transactions are regularly reported by executives at companies like LHC Group, Encompass Health, and other healthcare providers.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive to cover tax obligations.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/27/2024 | Date of the stock disposal transaction. |
| 12/31/2024 | Date of signature of the report. |
Keywords
Amedisys, Richard Ashworth, stock disposal, restricted stock units, tax obligations, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.